Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox and Psychotherapy for Fibromyalgia
NCT02078791Phase 4Completed
- Sponsor
- Universitat Rovira i Virgili
- Start
- Jul 2012
- Primary completion
- Sep 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of botulinum toxin type A in fibromyalgia (FM) (3 arms), sponsored by Universitat Rovira i Virgili. Primary endpoint: Visual Analogical Scale Pain Perception at 2 months. Started Jul 2012; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT02078791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02078791.